Literature DB >> 33830365

Fatal Pandoraea nosoerga infection after combined liver-lung transplantation for cystic fibrosis: a recontamination by the pre-transplantation strain.

Lucie Peyclit1,2, Sophie Alexandra Baron1,2, Martine Reynaud-Gaubert1,2,3, Nadim Cassir1,2,3, Jean-Marc Rolain4,5.   

Abstract

A 26-year-old girl with a longstanding colonization by Pandoraea nosoerga underwent liver-lung transplantation for cystic fibrosis (CF) in 2018. Her brother also suffering from CF was also colonized by P. nosoerga. Despite appropriate perioperative antibiotic therapy, she had post-transplant bacteremic pneumonia caused by extensively drug-resistant P. nosoerga. Drug repurposing was used to optimize treatment options. The cause of post-transplant contamination was studied by comparative whole-genome sequencing including pre- and post-transplant strains and her brother's strains. Post-transplant contamination appeared to be due to her own pre-transplant strain, emphasizing the urgent need to study and implement effective decontamination protocols before transplantation.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Comparative genomic; Cystic fibrosis; Drug repurposing; Extensively drug-resistant bacteria; Pandoraea

Mesh:

Substances:

Year:  2021        PMID: 33830365     DOI: 10.1007/s10096-021-04235-0

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  15 in total

Review 1.  The evolution of lung transplantation for cystic fibrosis: A 2017 update.

Authors:  Gregory Snell; Anna Reed; Marc Stern; Denis Hadjiliadis
Journal:  J Cyst Fibros       Date:  2017-07-12       Impact factor: 5.482

Review 2.  How to discover new antibiotic resistance genes?

Authors:  Linda Hadjadj; Sophie Alexandra Baron; Seydina M Diene; Jean-Marc Rolain
Journal:  Expert Rev Mol Diagn       Date:  2019-03-21       Impact factor: 5.225

Review 3.  Infections after lung transplantation.

Authors:  Mario Nosotti; Paolo Tarsia; Letizia Corinna Morlacchi
Journal:  J Thorac Dis       Date:  2018-06       Impact factor: 2.895

Review 4.  The microbiome and emerging pathogens in cystic fibrosis and non-cystic fibrosis bronchiectasis.

Authors:  Heather Green; Andrew M Jones
Journal:  Semin Respir Crit Care Med       Date:  2015-03-31       Impact factor: 3.119

5.  Infection with Burkholderia cepacia in cystic fibrosis: outcome following lung transplantation.

Authors:  C Chaparro; J Maurer; C Gutierrez; M Krajden; C Chan; T Winton; S Keshavjee; M Scavuzzo; E Tullis; M Hutcheon; S Kesten
Journal:  Am J Respir Crit Care Med       Date:  2001-01       Impact factor: 21.405

6.  Combined Lung-Liver and Delayed Kidney Transplantation for Cystic Fibrosis Clinical Approach and Outcome: A Case Report.

Authors:  Theodore Zhang; M Brent Price; Nicole Bravo; Joshua A Villarreal; Michael L Kueht; John Moore Vierling; Ronald Cotton; Thao Galvan; Christine Ann O'Mahony; John A Goss; Abbas Rana
Journal:  Transplant Proc       Date:  2020-05-07       Impact factor: 1.066

Review 7.  Antibiotic resistance in Burkholderia species.

Authors:  Katherine A Rhodes; Herbert P Schweizer
Journal:  Drug Resist Updat       Date:  2016-07-30       Impact factor: 18.500

Review 8.  Lung transplantation in cystic fibrosis patients with difficult to treat lung infections.

Authors:  Lieven Dupont
Journal:  Curr Opin Pulm Med       Date:  2017-11       Impact factor: 3.155

9.  Worldwide clinical practices in perioperative antibiotic therapy for lung transplantation.

Authors:  Benjamin Coiffard; Eloi Prud'Homme; Sami Hraiech; Nadim Cassir; Jérôme Le Pavec; Romain Kessler; Federica Meloni; Marc Leone; Pascal Alexandre Thomas; Martine Reynaud-Gaubert; Laurent Papazian
Journal:  BMC Pulm Med       Date:  2020-04-29       Impact factor: 3.317

10.  Comparative Genomics of Pandoraea, a Genus Enriched in Xenobiotic Biodegradation and Metabolism.

Authors:  Charlotte Peeters; Evelien De Canck; Margo Cnockaert; Evie De Brandt; Cindy Snauwaert; Bart Verheyde; Eliza Depoorter; Theodore Spilker; John J LiPuma; Peter Vandamme
Journal:  Front Microbiol       Date:  2019-11-06       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.